These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP). Markowitz LE; Dunne EF; Saraiya M; Chesson HW; Curtis CR; Gee J; Bocchini JA; Unger ER; MMWR Recomm Rep; 2014 Aug; 63(RR-05):1-30. PubMed ID: 25167164 [TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus vaccination 2020 guideline update: American Cancer Society guideline adaptation. Saslow D; Andrews KS; Manassaram-Baptiste D; Smith RA; Fontham ETH; CA Cancer J Clin; 2020 Jul; 70(4):274-280. PubMed ID: 32639044 [TBL] [Abstract][Full Text] [Related]
5. Use of a 2-Dose Schedule for Human Papillomavirus Vaccination - Updated Recommendations of the Advisory Committee on Immunization Practices. Meites E; Kempe A; Markowitz LE MMWR Morb Mortal Wkly Rep; 2016 Dec; 65(49):1405-1408. PubMed ID: 27977643 [TBL] [Abstract][Full Text] [Related]
6. Meaningful Methods for Increasing Human Papillomavirus Vaccination Rates: An Integrative Literature Review. Vollrath K; Thul S; Holcombe J J Pediatr Health Care; 2018; 32(2):119-132. PubMed ID: 28918994 [TBL] [Abstract][Full Text] [Related]
7. Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices. Petrosky E; Bocchini JA; Hariri S; Chesson H; Curtis CR; Saraiya M; Unger ER; Markowitz LE; MMWR Morb Mortal Wkly Rep; 2015 Mar; 64(11):300-4. PubMed ID: 25811679 [TBL] [Abstract][Full Text] [Related]
8. Human papillomavirus vaccination coverage using two-dose or three-dose schedule criteria. Lin X; Rodgers L; Zhu L; Stokley S; Meites E; Markowitz LE Vaccine; 2017 Oct; 35(43):5759-5761. PubMed ID: 28890189 [TBL] [Abstract][Full Text] [Related]
9. Human Papillomavirus Vaccination for Adults: Updated Recommendations of the Advisory Committee on Immunization Practices. Meites E; Szilagyi PG; Chesson HW; Unger ER; Romero JR; Markowitz LE MMWR Morb Mortal Wkly Rep; 2019 Aug; 68(32):698-702. PubMed ID: 31415491 [TBL] [Abstract][Full Text] [Related]
10. Why the American Academy of Pediatrics recommends initiating HPV vaccine at age 9. O'Leary ST Hum Vaccin Immunother; 2022 Nov; 18(6):2146434. PubMed ID: 36404635 [TBL] [Abstract][Full Text] [Related]
11. Strategies to improve human papillomavirus vaccination rates among adolescents in family practice settings in the United States: A systematic review. Eisenhauer L; Hansen BR; Pandian V J Clin Nurs; 2021 Feb; 30(3-4):341-356. PubMed ID: 33270305 [TBL] [Abstract][Full Text] [Related]
12. Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). Markowitz LE; Dunne EF; Saraiya M; Lawson HW; Chesson H; Unger ER; ; MMWR Recomm Rep; 2007 Mar; 56(RR-2):1-24. PubMed ID: 17380109 [TBL] [Abstract][Full Text] [Related]
13. Strengthening the Effectiveness of National, State, and Local Efforts to Improve HPV Vaccination Coverage in the United States: Recommendations From the National Vaccine Advisory Committee. Approved by the National Vaccine Advisory Committee on June 25, 2018 Public Health Rep; 2018; 133(5):543-550. PubMed ID: 30091942 [TBL] [Abstract][Full Text] [Related]
14. Implementation of Strategies to Improve Human Papillomavirus Vaccine Coverage: A Provider Survey. Walling EB; Dodd S; Bobenhouse N; Reis EC; Sterkel R; Garbutt J Am J Prev Med; 2019 Jan; 56(1):74-83. PubMed ID: 30573149 [TBL] [Abstract][Full Text] [Related]
15. A systematic literature review of human papillomavirus vaccination strategies in delivery systems within national and regional immunization programs. Felsher M; Shumet M; Velicu C; Chen YT; Nowicka K; Marzec M; Skowronek G; Pieniążek I Hum Vaccin Immunother; 2024 Dec; 20(1):2319426. PubMed ID: 38410931 [TBL] [Abstract][Full Text] [Related]
16. National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2016. Walker TY; Elam-Evans LD; Singleton JA; Yankey D; Markowitz LE; Fredua B; Williams CL; Meyer SA; Stokley S MMWR Morb Mortal Wkly Rep; 2017 Aug; 66(33):874-882. PubMed ID: 28837546 [TBL] [Abstract][Full Text] [Related]
17. National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2018. Walker TY; Elam-Evans LD; Yankey D; Markowitz LE; Williams CL; Fredua B; Singleton JA; Stokley S MMWR Morb Mortal Wkly Rep; 2019 Aug; 68(33):718-723. PubMed ID: 31437143 [TBL] [Abstract][Full Text] [Related]
18. On surmounting the barriers to HPV vaccination: we can do better. Attia AC; Wolf J; Núñez AE Ann Med; 2018 May; 50(3):209-225. PubMed ID: 29316825 [TBL] [Abstract][Full Text] [Related]
19. FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP). Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2010 May; 59(20):626-9. PubMed ID: 20508593 [TBL] [Abstract][Full Text] [Related]